United Therapeutics Corporation (UTHR) Rating Reiterated by Oppenheimer Holdings, Inc.

United Therapeutics Corporation (UTHR) Rating Reiterated by Oppenheimer Holdings, Inc.


's stock had its "buy" rating reiterated by stock analysts at Oppenheimer Holdings, Inc. in a research note issued to investors on Tuesday. A number of other brokerages have also recently issued reports on UTHR.



from Biotech News